Want to see IN:SHALBY full AI Analyst Report?
Shalby Ltd. (SHALBY) Stock Price & Analysis
SHALBY Stock Chart & Stats
- Day’s Range
- INR 119.65 - INR 122.55
- 52-Week Range
- INR 111.00 - INR 250.85
- Previous Close
- INR 122.65
- Volume
- 41.00K
- Average Volume (3M)
- 5,221
- Market Cap
- INR 13.06B
- Enterprise Value
- INR 18.58B
- Total Cash (Recent Filing)
- INR 841.97M
- Total Debt (Recent Filing)
- INR 0
- Price to Earnings (P/E)
- 34.1
- Beta
- 1.29
- Next Earnings
- Nov 03, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Sep 19, 2024
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth
Revenue has more than doubled across the reported period, demonstrating sustained expansion in Shalby’s hospital services business. Continued top-line growth can support greater scale across its network, broaden patient reach, and create a stronger base for rebuilding profitability if operating efficiency improves.
Specialized Healthcare Position
A recognized position in orthopedic and joint-replacement care, combined with multi-specialty hospital capabilities, gives Shalby a defined clinical identity and broader service offering. This combination can support patient referrals, utilization across specialties, and durable demand for complex medical care.
Capital Cushion
A growing asset base alongside broadly stable equity provides a meaningful capital cushion for a hospital operator. Although leverage has increased, the existing equity base can help support continued operations and investment while management works to improve returns and cash generation.
Bears Say
Negative Cash Generation
Sustained negative operating and free cash flow means reported growth is not currently translating into internally generated liquidity. Cash consumption can increase reliance on external funding, restrict investment flexibility, and make execution more vulnerable if operating needs or capital requirements remain elevated.
Rising Leverage
The sharp increase in debt relative to equity raises financial risk as the company expands. Higher leverage can reduce flexibility to fund hospital growth internally, increase sensitivity to operating setbacks, and place greater importance on restoring cash generation and improving returns on capital.
Margin Compression
Margin deterioration has weakened the quality of Shalby’s revenue growth and left less earnings cushion against operating pressures. The decline from earlier profitability peaks, together with modest FY2026 ROE of about 3.7%, indicates that additional scale has not yet translated into efficient shareholder returns.
Shalby Ltd. News
SHALBY FAQ
What was Shalby Ltd.’s price range in the past 12 months?
What is Shalby Ltd.’s market cap?
When is Shalby Ltd.’s upcoming earnings report date?
How were Shalby Ltd.’s earnings last quarter?
Is Shalby Ltd. overvalued?
Does Shalby Ltd. pay dividends?
What is Shalby Ltd.’s EPS estimate?
How many shares outstanding does Shalby Ltd. have?
What happened to Shalby Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Shalby Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Shalby Ltd.
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; dermatology; emergency and general medicine; cochlear implants and balloon sinuplasty; gastroenterology, obesity surgery, and endoscopy and laparoscopy; intensive and critical care; nephrology, urology, kidney transplant, dialysis, and interventional nephrology; and general surgery comprising varicose, hernia, and piles surgery. The company also provides liver transplant; maxillofacial surgery; neurology, ideal stroke treatment, epilepsy, endovascular/interventional neurosurgery, and trans cranial doppler; obstetrics and gynaecology; surgical oncology, medical oncology, radiation oncology, bone marrow transplant, onco-psychology, onco-dietetics, onco-physiotherapy, and home care; ophthalmology; paediatrics; pathology and microbiology; psychiatry; pulmonology and chest; and interventional and diagnostic radiology. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is based in Ahmedabad, India.
- Sector
- General
- Industry
- Medical - Care Facilities
- CEO
- Vikram Indrajit Shah
- Employees
- 2,217
- Website
- www.shalby.org
- Address
- B-301 & 302, Mondeal Heights, Ahmedabad, GJ, 380015, IN
Shalby Ltd. (SHALBY) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 6 | 12 |
| Technical Analysis | 1 | 6 | 3 |
| Moving Averages | 3 | 0 | 9 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| IN:APOLLOHOSPApollo Hospitals Enterprise Limited | ||
| IN:ASTERDMAster DM Healthcare Ltd. | ||
| IN:FORTISFortis Healthcare Ltd. | ||
| IN:MAXHEALTHMax Healthcare Institute Ltd | ||
| IN:MEDANTAGlobal Health Limited |